WASHINGTON, DC – The Subcommittee on Energy and Power, chaired by Rep. Ed Whitfield (R-KY), today continued its American Energy Security and Innovation hearing series with a focus on grid reliability challenges that arise from the nation’s shifting energy resource landscape.
Energy and Power Subcommittee Continues Examination of Changing Energy Landscape, Grid Reliability, and AffordabilityMay 9, 2013 | Press Release
Committee Leaders Press HHS to Comply with Congressional Examination of Whether “Prevention” Grants Violated Anti-Lobbying RulesMay 9, 2013 | Press Release
WASHINGTON, DC – House Energy and Commerce Committee leaders today pushed Health and Human Services Secretary Kathleen Sebelius to fully comply with the panel’s investigation into the potentially illegal use and waste of taxpayer dollars through the Communities Putting Prevention to Work (CPPW) and Community Transformation Grant (CTG) programs.
WASHINGTON, DC – Rep. Mike Pompeo (R-KS) today introduced H.R. 1900, the Natural Gas Pipeline Permitting Reform Act, a bipartisan bill to modernize the federal review process for natural gas pipeline permit applications.
In Wake of Gosnell Trial, Committee Leaders Examine How States Monitor and Regulate Abortion Clinics and Protect Women’s HealthMay 9, 2013 | Press Release
WASHINGTON, DC – Leaders of the House Energy and Commerce Committee yesterday sent a letter to public health officials in all 50 states and the District of Columbia to examine how each state regulates and monitors abortion clinics and protects the health and safety of women. The trial of Dr.
Health Subcommittee Advances Bipartisan Bills to Reauthorize Animal Drug User Fee Programs and Secure America’s Prescription Drug Supply ChainMay 8, 2013 | Press Release
WASHINGTON, DC – The Subcommittee on Health, chaired by Rep. Joe Pitts (R-PA), today advanced legislation reauthorizing two important drug user fee programs for new and generic animal drugs and a bill to secure America’s prescription drug supply chain.
WASHINGTON, DC – Oversight and Investigations Subcommittee Chairman Tim Murphy (R-PA), Chairman Emeritus Joe Barton (R-TX), and Vice Chairman of the Oversight and Investigations and Health Subcommittees Michael C. Burgess, M.D. (R-TX) today expressed concern about the stimulant dimethylamylamine (DMAA) being used in certain products that are marketed as dietary supplements. In April 2012, the Food and Drug Administration sent Warning Letters to 10 companies noting that DMAA raises blood pressure and could precipitate heart attacks.